ACS Medicinal Chemistry Letters · 2019 · 10 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsHedgehog SignalingStructure-activity Relationship AnalysisHedgehog Pathway InhibitorsHedgehog Signaling InhibitionMouse Liver MicrosomesOptimization Of Drug-like PropertiesOptimization Of Pharmacokinetic PropertiesPharmacological Targeting Of Hedgehog SignalingStructure - Activity Relationship OptimizationTruncation
We conducted a structure–activity relationship study to explore simplified analogues of the itraconazole (ITZ) scaffold for their ability to inhibit the hedgehog (Hh) signaling pathway. These analogues were based on exploring the effects of chemical modifications to the linker and triazolone/side chain region of ITZ. Analogue 11 was identified as the most potent compound in our first generation, with an IC50 value of 81 nM in a murine Hh-dependent basal cell carcinoma. Metabolic identification studies led us to identify truncated piperazine (26) as the major metabolite in human liver microsomes (HLMs) and an improved Hh pathway inhibitor (IC50 = 22 nM). This work verifies that continued truncation of the ITZ scaffold is a practical method to maintain potent anti-Hh activity while also reducing the molecular weight for the ITZ scaffold and achieving improved pharmacokinetic properties.
18
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro et al. · New England Journal of Medicine · 2012 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +17
<i>Smoothened</i> Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch, Gerrit J.P. Dijkgraaf, Bruno Alicke et al. · Science · 2009 · 844 citations · Full text
Medicine, Cancer Biology, Oncology +17
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim, Jean Y. Tang, Ruoyu Gong et al. · Cancer Cell · 2010 · 519 citations · Full text
Medicine, Oncology, Pharmacology +14
Michael R. Migden, Alexander Guminski, Ralf Gutzmer et al. · The Lancet Oncology · 2015 · 429 citations
Medicine, Dermatology, Oncology +7
GDC-0449—A potent inhibitor of the hedgehog pathway
Kirk Robarge, Shirley A. Brunton, Georgette M. Castanedo et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 387 citations · Full text